Dr. Reddy's Laboratories: Notice of Loss of Share Certificates Published
Dr. Reddy's Laboratories published a notice on February 12, 2026, regarding lost share certificates. Shareholders must lodge claims within 15 days. Separately, SEBI's special window for dematerialising physical securities is open from February 5, 2026, to February 4, 2027.
The announcement pertains to lost share certificates, which is a procedural matter for individual shareholders and does not have a significant impact on the company's overall operations or financial performance. The mention of the SEBI special window is a general market development.
The announcement is a routine regulatory filing regarding lost share certificates and a general update on a SEBI initiative. It does not contain any specific financial performance or strategic information that would indicate a positive or negative sentiment.
Dr. Reddy's Laboratories Limited has published a notice regarding the loss of share certificates by its shareholders. The notice, published in Business Standard and Nava Telangana on February 12, 2026, informs the public about the reported loss or misplacement of specific share certificates. Registered shareholders or claimants have applied for the issuance of duplicate share certificates. The company cautions the public against dealing with the mentioned share certificates and requests anyone with a claim to lodge it at the company's registered office within 15 days of the notice publication. After this period, no claims will be entertained, and duplicate certificates will be issued.
The announcement also includes details of specific shareholders, certificate numbers, number of shares, distinctive numbers, and folio numbers for the lost certificates. The face value of the shares is ₹5.
Separately, the announcement mentions a special window opened by SEBI for the transfer and dematerialisation of physical securities sold prior to April 1, 2019. This window is open for one year from February 5, 2026, to February 4, 2027, and is also available for previously rejected or returned transfer requests. Securities transferred during this period will be mandatorily credited in demat mode and will be under a one-year lock-in period.
Additionally, the announcement from Kalyani Steels Limited regarding the special window for physical securities transfer and dematerialisation is included as a publication reference.
What to do with a filing like this
Dr. Reddy's Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dr. Reddy's Laboratories Limited. Read the original for the full detail.